Skip to main content

Table 3 Description of ocular parameters at each moment of evaluation and result of comparative tests

From: Correlations between subfoveal choroidal thickness, macular thickness, and visual outcome in neovascular age-related macular degeneration using swept source OCT: insights from intravitreal aflibercept treatment

Characteristic

Pre

Post

Diference

P-valuea

VA (logMAR)

1.00 ± 0.39 (1.00)

0.55 ± 0.27 (0.48)

− 0.45 ± 0.22 (− 0.40)

0.0006

Macular thickness (μm)

323.40 ± 103.39 (284)

231.60 ± 64.48 (227)

− 91.80 ± 89.46 (− 83)

0.0010

Subfoveal choroidal thickness (μm)

206.33 ± 92.96 (226)

172.00 ± 87.16 (172)

− 34.33 ± 55.45 (− 17)

0.0054

IOP (mmHg)

12.27 ± 0.88 (12)

12.20 ± 0.77 (12)

− 0.07 ± 0.70 (0)

0.9411

  1. aP-value for the Wilcoxon signed-rank test. Values less than 0.05 show a statistically significant difference between groups